Holon, Israel: Cannabis treatment is associated with quality of life improvements in patients with treatment-resistant fibromyalgia (FM), according to the results of a prospective cohort study published in the journal Pain Practice. Israeli researchers evaluated cannabis’ efficacy in a cohort of 30 patients diagnosed with fibromyalgia. All of the study’s participants had previously failed to respond to conventional pharmaceutical treatments. Investigators assessed patients’ quality …
Alberta, Canada: Patients suffering from headache disorders frequently experience relief from the use of cannabis, according to survey data published in the Canadian Journal of Neurology. Researchers surveyed 200 patients associated with a tertiary headache clinic in Calgary regarding their use of cannabis products. (Cannabis is legal in Canada for both medical and adult use.) Over one-third of respondents (34 percent) acknowledged currently engaging …
Tel Aviv, Israel: Tourette syndrome (TS) patients’ who consume cannabis products report significant improvements in their quality of life and reduce their intake of prescription medicines, according to data published in the journal Cannabis and Cannabinoid Research. Israeli researchers assessed patients’ symptoms immediately prior to and following six months of cannabis treatment. Study participants generally inhaled THC-dominant cannabis flowers, though some patients also consumed …
Boston, MA: Patients with moderate-to-severe anxiety experience symptom improvements and better cognitive performance following the daily administration of full spectrum CBD extracts, according to open-label trial data published in the journal Communications Medicine. A team of investigators affiliated with Harvard Medical School assessed the safety and efficacy of CBD extracts in a cohort of anxiety patients over a four-week period. Trial participants consumed oral …
Providence, RI: Cannabis use is associated with greater levels of physical activity in HIV+ positive patients, according to data published in the journal AIDS Care. A team of researchers from Brown University in Rhode Island and Boston University’s School of Public Health assessed the relationship between self-reported substance use and exercise engagement in a cohort of HIV+ patients. Investigators reported that those who reported …
HILLSBORO, ORE. (PRWEB) NOVEMBER 16, 2022 In a new study published in the journal Psychoactives, some of the most influential minds in the industry today are breaking down the current understanding of what makes a “quality” cannabis experience. And to do so, they’ve done something even more groundbreaking: they’ve asked the consumer. The study is the result of years of work …
London, United Kingdom: The sustained vaporization of THC-dominant cannabis flowers improves health-related quality of life measurements in patients suffering from chronic pain and anxiety-related disorders, according to observational data published in the journal Biomedicines. A team of British and Spanish investigators assessed cannabis’ efficacy in a cohort of 451 British patients authorized to consume cannabis flowers for treatment-resistant pain and/or anxiety. Patients in the …
New York, NY: The use of CBD can mitigate various symptoms associated with opioid withdrawal and it should be considered as an adjunctive treatment for patients, according to a review of the relevant literature published in the journal Cannabis and Cannabinoid Research. Researchers affiliated with the Icahn School of Medicine at Mount Sinai identified 41 clinical studies evaluating the use of CBD for symptoms …
Toronto, Canada: The twice-daily administration of plant-derived CBD-dominant extracts is “an effective treatment for managing symptoms associated with autism,” according to a case report published in the journal Cureus. A team of Canadian investigators documented the treatment of a nine-year old patient diagnosed with nonverbal autism spectrum disorder (ASD). The patient received twice-daily dosing of a high-CBD/low-THC extract oil. Researchers reported, “The child patient …
New York, Nov. 09, 2022 (GLOBE NEWSWIRE) — According to The Insight Partners new research study titled “Cannabis Testing Market Size, Share, Growth and Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Type, End User, Portability, and Geography,” the global cannabis testing market was valued at USD 1.5 billion in 2021 and is projected to reach USD …